Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 1
Location: United States, NY
New Onset Type 1 Diabetes: Role of Exenatide
The main purpose of this study is to see if the study medication Byetta improves after meal blood sugars in kids and adults with newly diagnosed Type 1 Diabetes. We will also compare how quickly food leaves the stomach in healthy controls when compared to the kids with diabetes getting the medication during the study. Study includes 4 outpatient visits over a 4-5 month period for kids with diabetes. Kids with diabetes will be compensated to a total of 570 dollars.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 180695
Date Last Changed:
October 16, 2014
Ranjitha Katikaneni, Jeniece TrastThe Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & MontefioreMontefiore Medical Center
Division of Pediatric Endocrinology
111 East 210th StreetBronx, NY 10467Phone: (718) 741-2195; (718) 920-6191
The Harold & Muriel Block Institute for Clinical and Translational Research at Einstein & Montefiore
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2016 CenterWatch.